Compare RCEL & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCEL | HCAT |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | 226 | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.0M | 152.1M |
| IPO Year | N/A | 2019 |
| Metric | RCEL | HCAT |
|---|---|---|
| Price | $5.41 | $1.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 11 |
| Target Price | ★ $7.17 | $4.25 |
| AVG Volume (30 Days) | 196.9K | ★ 877.4K |
| Earning Date | 01-01-0001 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.98 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $306,584,000.00 |
| Revenue This Year | $21.69 | $3.30 |
| Revenue Next Year | $49.58 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.60 |
| 52 Week Low | $3.22 | $1.67 |
| 52 Week High | $10.28 | $5.09 |
| Indicator | RCEL | HCAT |
|---|---|---|
| Relative Strength Index (RSI) | 69.93 | 33.70 |
| Support Level | $3.33 | N/A |
| Resistance Level | $6.16 | $2.45 |
| Average True Range (ATR) | 0.34 | 0.13 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 87.69 | 6.82 |
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.